Beyond Air, Inc. Restricted Cash Equivalents, Current
Beyond Air, Inc. (XAIR) had Restricted Cash Equivalents, Current of $10.11 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashEquivalentsCurrent · last filed 2022-11-08
- 2022-09-30: Restricted Cash Equivalents, Current $10.11M.
- 2022-06-30: Restricted Cash Equivalents, Current $9.99M.
- 2022-03-31: Restricted Cash Equivalents, Current $9.99M.
- 2021-12-31: Restricted Cash Equivalents, Current $9.24M.
| Period end | Restricted Cash Equivalents, Current |
|---|---|
| 2022-09-30 | $10.11M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $9.99M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $9.99M 10-Q · filed 2022-11-08 |
| 2021-12-31 | $9.24M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.05M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $637.00K 10-K · filed 2022-06-29 |
| 2020-12-31 | $638.00K 10-Q · filed 2022-02-10 |
| 2020-09-30 | $636.00K 10-Q · filed 2021-11-12 |
| 2020-06-30 | $636.32K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |